ESMO Expert video report on CNS malignancies

M. Preusser reports on brain tumour studies results presented at ASCO 2019. He details some new data from the CATNON trial focusing on molecular subtybes such as IDH mutated anaplastic glioma, and shows intracranial responses with larotrectinib in NTRK fusion positive glioma and also in patients with brain matastases from other tumours. He also reports on results from a randomised multicentre trial in meningioma.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings